1 Min Read
Feb 22 (Reuters) - NeuroVive Pharmaceutical Ab:
* Says appoints recognized scientific advisors and enters research agreements in NASH and hepatocellular carcinoma Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.